Concepedia

Andreas Cornelius

AC

Statistics

Publications

5

Citations

197

H-Index

5

Active since

2017

Affiliations

Molecular Partners (Switzerland)(Current)

Spiez Laboratory

University of Lausanne

Thermo Fisher Scientific (Netherlands)

Utrecht University

Andreas Cornelius is an author at Molecular Partners (Switzerland) specializing in medicine, virology, and drug discovery.

Top concepts

Publications per year

2017–2022

5

Publications

5

Design and characterization of MP0250, a tri-specific anti-HGF/anti-VEGF DARPin® drug candidate

Hans Binz, Talitha R. Bakker, Douglas J. Phillips et al. · mAbs · 2017 · 68 citations · Full text

, , +16

The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants

Sylvia Rothenberger, Daniel L. Hurdiss, Marcel Walser et al. · Nature Biotechnology · 2022 · 56 citations · Full text

Highly potent anti-SARS-CoV-2 multivalent DARPin therapeutic candidates

Marcel Walser, Sylvia Rothenberger, Daniel L. Hurdiss et al. · 2020 · 34 citations · Full text

, , +12

MP0250, a VEGF and HGF neutralizing DARPin® molecule shows high anti-tumor efficacy in mouse xenograft and patient-derived tumor models

Ulrike Fiedler, Savira Ekawardhani, Andreas Cornelius et al. · Oncotarget · 2017 · 22 citations · Full text

Ensovibep, a novel trispecific DARPin candidate that protects against SARS-CoV-2 variants

Sylvia Rothenberger, Daniel L. Hurdiss, Marcel Walser et al. · 2021 · 17 citations · Full text

, , +15

1–5 of 5